FOXO1 and metabolic syndrome: The pathway by which IR declines to suppress gluconeogenesis, (hyperglycemia) caused by FoxO1-phosphoenolpyruvate carboxy-kinase (PEPCK), while stimulating lipogenesis induced by sterol regulatory-element binding proteins (SREBP)-1c (dyslipidemia), remains unclear.